Ulcer Clinical Trials in Los Angeles, California
27 recruitingLos Angeles, California
Showing 1–20 of 27 trials
Recruiting
Phase 2
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
Ulcerative Colitis
Eli Lilly and Company252 enrolled149 locationsNCT07186101
Recruiting
Not Applicable
BOOM-IBD2 Pivotal Clinical Trial
Inflammatory Bowel DiseasesUlcerative Colitis
Boomerang Medical137 enrolled19 locationsNCT06571669
Recruiting
Phase 2Phase 3
A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
Colitis Ulcerative
Bristol-Myers Squibb120 enrolled90 locationsNCT05076175
Recruiting
Phase 3
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Colitis Ulcerative
Janssen Research & Development, LLC882 enrolled393 locationsNCT07196748
Recruiting
Phase 2
The Use of Butyrate Therapy in Pediatric Ulcerative Colitis
Ulcerative Colitis
Children's Hospital Los Angeles10 enrolled1 locationNCT05218850
Recruiting
Phase 3
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis
Moderately to Severely Active Ulcerative Colitis
Hoffmann-La Roche350 enrolled200 locationsNCT06588855
Recruiting
Phase 3
A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Crohn's DiseaseUlcerative Colitis
Takeda240 enrolled98 locationsNCT05442567
Recruiting
Phase 3
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis
Sanofi980 enrolled191 locationsNCT07184996
Recruiting
Phase 2
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis
Takeda207 enrolled141 locationsNCT06254950
Recruiting
Phase 3
A Double Blind Study Performed to Evaluate the Efficacy and the Safety of EscharEx in Debridement of VLU (VALUE)
Venous Leg Ulcer (VLU)
MediWound Ltd216 enrolled25 locationsNCT06568627
Recruiting
Phase 4
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
Ulcerative Colitis
Takeda65 enrolled49 locationsNCT06095128
Recruiting
Phase 3
A Study to Assess the Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis Treated With Risankizumab Compared to Vedolizumab
Ulcerative Colitis
AbbVie530 enrolled270 locationsNCT06880744
Recruiting
Not Applicable
Impact of Prebiotics in Ulcerative Colitis
Crohn DiseaseUlcerative Colitis
University of California, Los Angeles70 enrolled1 locationNCT06495658
Recruiting
Not Applicable
Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC)
Ulcerative Colitis
Northwestern University126 enrolled13 locationsNCT05987852
Recruiting
Not Applicable
Effects of Pomegranate Juice on Ulcerative Colitis
Ulcerative Colitis (Disorder)
University of California, Los Angeles30 enrolled2 locationsNCT07115862
Recruiting
DFC 004 Biomarkers for Active Diabetic Foot Ulcers
DiabetesDiabetic Foot UlcerDiabetic Foot
University of Michigan5,000 enrolled8 locationsNCT06104969
Recruiting
Not Applicable
Evaluating a Lifestyle Intervention to Prevent Recurrence of Diabetic Foot Ulcers
Diabetic Foot UlcerDiabetic FootFoot Ulcer, Diabetic+1 more
University of Southern California60 enrolled3 locationsNCT06487780
Recruiting
Not Applicable
IDEAL: Efficacy of Porcine Placental Extracellular Matrix Augmented Plus Standard of Care (SOC) Versus SOC Alone for the Management of Diabetic Foot Ulcers
Wound HealUlcer
ConvaTec Inc.194 enrolled9 locationsNCT06616844
Recruiting
Not Applicable
Rising Tide - Amniotic Tissue(s) Treatments for Chronic Diabetic Foot Ulcers
Diabetic Foot Ulcer (DFU)Chronic Foot Ulcers
Tides Medical240 enrolled9 locationsNCT06681428
Recruiting
Not Applicable
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
Crohn DiseaseUlcerative Colitis
University of California, San Diego250 enrolled22 locationsNCT05230173